Drug
Debio 1453p
Debio 1453p: highest development phase Phase 1, developed by Debiopharm International SA. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Debiopharm International SA
Trials
| Drug | Phase | Indication |
|---|---|---|
| Debio 1453P NCT07035769 | Phase 1 |
Latest
No recent events.
Follow Debio 1453p on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.